Glomerulonephritis, Membranous: all 146 studies
Page 1 of 2. Open to participants first (60), then studies with results posted, then the rest; newest registration first within each.
- Pediatric Longitudinal Glomerular Disease: a PNRC Multi-Institutional Cohort StudyRecruitingNCT07931170
- Early PLA2R Status in Severe Anti-PLA2R-mediated Membranous Nephropathy and Long Term Kidney Outcome.Not yet recruitingNCT07930676
- MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)Not yet recruitingNCT07892651
- Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous NephropathyRecruitingNCT07861204Phase 2/3
- A Phase 3 Study of Inebilizumab in Participants With Primary Membranous NephropathyRecruitingNCT07851220Phase 3
- Evaluation of the Efficacy of Zuberitamab Injection in Patients With Primary Membranous NephropathyNot yet recruitingNCT07830433Phase 3
- Single-cell RNA Sequencing (scRNA-seq) to Investigate the Mechanisms Underlying the Induction of Regulatory T Cells in Patients With Extramembranous Glomerulonephritis Treated With RituximabNot yet recruitingNCT07811557Not applicable
- Clinical Prediction Model for Disease Progression in Primary Membranous NephropathyNot yet recruitingNCT07785739
- A Phase I/II Open-label, Single-arm, Multicenter Clinical Study to Evaluate the Safety and Efficacy of FKC289 in Subjects With Relapsed/Refractory Membranous NephropathyNot yet recruitingNCT07765537Phase 1/2
- Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II TrialNot yet recruitingNCT07721363Phase 2
- A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney DiseaseRecruitingNCT07571746Phase 2
- Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune NephropathyNot yet recruitingNCT07535138Early Phase 1
- Clinical Study of Anti-CD19/BCMA Universal Chimeric Antigen Receptor T Cells (UCAR-T) in the Treatment of Refractory Idiopathic Membranous Nephropathy (IMN)Not yet recruitingNCT07423572Early Phase 1
- Omics of Rituximab-resistanceNot yet recruitingNCT07416942
- Rivaroxaban in Idiopathic Membranous NephropathyRecruitingNCT07404436Phase 4
- A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in the Treatment of Immune-mediated Kidney DiseasesNot yet recruitingNCT07389499Early Phase 1
- Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous NephropathyRecruitingNCT07289763Phase 2
- Safety and Efficacy of CD19 Chimeric Antigen Receptor T-Cell (CAR-T) in the Treatment of Refractory Membranous NephropathyRecruitingNCT07266181Phase 1
- A Phase I Study of YK012 in Primary Membranous NephropathyNot yet recruitingNCT07234474Phase 1
- Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)RecruitingNCT07204275Phase 2/3
- Obinutuzumab Induced Decreases of PLA2R Antibodies in Membranous Nephropathy: a Pilot StudyRecruitingNCT07163611Phase 2/3
- Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)RecruitingNCT07157787Phase 2
- A Phase 2 Study of Budoprutug in Subjects With Primary Membranous NephropathyRecruitingNCT07096843Phase 2
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active GlomerulonephritisRecruitingNCT07038382Phase 2
- A Study to Learn More About the Effects and Safety of JMT601 in Adults With Primary Membranous NephropathyNot yet recruitingNCT07029139Phase 2
- Epithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisRecruitingNCT07010250
- Study of YK012 in Primary Membranous NephropathyRecruitingNCT06982729Phase 1
- A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)RecruitingNCT06962800Phase 3
- A Real World Study About PMNRecruitingNCT06893328
- OBINOTUZUMAB Versus Cyclophosphamide + Glucocorticoids in Primary Membranous Nephropathy(Blossom Study)RecruitingNCT06781944Phase 3
- Raman Spectroscopy Diagnosis of Kidney DiseasesRecruitingNCT06760845
- IM19 CAR-T Cell Therapy for IgA Nephropathy Patients and Membranous Nephropathy PatientsNot yet recruitingNCT06690359Early Phase 1
- An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte DiseasesRecruitingNCT06664814Phase 2
- The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous NephropathyNot yet recruitingNCT06614985Phase 2
- Efficacy and Safety of Finerenone in Patients With Primary Membranous NephropathyRecruitingNCT06573411Phase 4
- A Clinical Study of B007 in the Treatment of Primary Membranous Nephropathy.RecruitingNCT06470191Phase 2/3
- Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)RecruitingNCT06341205Phase 3
- Circulating Factors in Nephrotic SyndromeNot yet recruitingNCT06315504
- the Effects of Different Treatment Schemes on Cognitive Function of Patients With Idiopathic Membranous NephropathyRecruitingNCT06245707Not applicable
- An Outcome Analysis of Primary Membranous NephropathyRecruitingNCT06242327
- National Registry of Rare Kidney DiseasesRecruitingNCT06065852
- Clinical Trial of PLA2R-IgG4 Detection Kit (Time-resolved Fluorescence Immunoassay)Enrolling by invitationNCT05861869
- Obinutuzumab in the Management of Idiopathic Membranous NephropathyNot yet recruitingNCT05845762
- Effect of Huaier Granule on the Treatment of Idiopathic Membranous NephropathyRecruitingNCT05839314Phase 4
- Correlation and Clinical Utility of Urinary Biomarker in Membranous GlomerulonephritisRecruitingNCT05688865
- Rituximab, Cyclophosphamide, and Corticosteroids in Primary Membranous NephropathyRecruitingNCT05679336Not applicable
- A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous NephropathyRecruitingNCT05668403Phase 1
- Prognostic Model of TAC in the Treatment of MNNot yet recruitingNCT05667922
- Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous NephropathyRecruitingNCT05514015Phase 4
- Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.RecruitingNCT05505500
- China Kidney Patient Trials NetworkRecruitingNCT05036850
- Different Immunosuppressive Treatment in iMNRecruitingNCT04745728Phase 3
- NEPTUNE Match StudyRecruitingNCT04571658Not applicable
- A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN and Severe ProteinuriaRecruitingNCT04456816Phase 2
- Immunopathological Analysis in a French National Cohort of Membranous NephropathyRecruitingNCT04326218Not applicable
- Autoreactive B Cells in Membranous NephropathyRecruitingNCT04095156
- Belimumab With Rituximab for Primary Membranous NephropathyRecruitingNCT03949855Phase 2
- KOrea Renal Biobank NEtwoRk System TOward NExt-generation AnalysisRecruitingNCT03929887
- Nephrotic Syndrome Study NetworkRecruitingNCT01209000
- Rituximab Plus Cyclosporine in Idiopathic Membranous NephropathyRecruitingNCT00977977Phase 2
- Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)TerminatedNCT05162066Phase 2Results posted
- Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous NephropathyTerminatedNCT04154787Phase 2Results posted
- Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN)CompletedNCT04145440Phase 1/2Results posted
- Phase II Study Assessing Safety and Efficacy of APL-2 in GlomerulopathiesCompletedNCT03453619Phase 2Results posted
- Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)CompletedNCT03285711Phase 2Results posted
- Adrenocorticotropic Hormone in Membranous NephropathyCompletedNCT03025828Phase 4Results posted
- Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721TerminatedNCT02682407Phase 2Results posted
- A Study of Belimumab in Idiopathic Membranous GlomerulonephropathyCompletedNCT01610492Phase 2Results posted
- Acthar for Treatment of Proteinuria in Membranous Nephropathy PatientsCompletedNCT01386554Phase 4Results posted
- Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous NephropathyCompletedNCT01282073Phase 3Results posted
- MEmbranous Nephropathy Trial Of RituximabCompletedNCT01180036Phase 2/3Results posted
- Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney DiseaseTerminatedNCT01129557Phase 4Results posted
- Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)CompletedNCT01129284Phase 4Results posted
- Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous GlomerulonephritisCompletedNCT00843856Phase 4Results posted
- Model Development and Application Based on Renal Pathology ImagesActive, not recruitingNCT07816874
- Immunophenotyping Profiling in Patients With Primary Nephrotic SyndromeCompletedNCT07702981
- Effect of B-cell Depleting Therapies on PLA2R-specific B Cells in Patients With Membranous NephropathyCompletedNCT06994468Not applicable
- Optimization of a Decision Formula for Optimal Timing of Immunosuppressive Therapy Initiation in Primary Membranous Nephropathy: A Multicenter Retrospective Cohort StudyActive, not recruitingNCT06924476
- A Phase II Study of Zuberitamab Injection in Patients With Primary Membranous NephropathyActive, not recruitingNCT06642909Phase 2
- REmission in Membranous Nephropathy International Trial (REMIT)WithdrawnNCT06120673Phase 3
- Interferon Alfa Therapy Based on Th17 Profile in Membranous NephropathyTerminatedNCT05941845Phase 2
- Clinical Study of Rituximab for the Treatment for Idiopathic Membranous Nephropathy With Nephrotic SyndromeActive, not recruitingNCT05914155Phase 3
- Analysis of T- and B-Cell Subpopulations in Membranous NephropathyCompletedNCT05894512
- A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous NephropathyActive, not recruitingNCT05862233Phase 3
- Study on the Application of Hyperspectral Imaging Technique in CTX Treatment of IMNStatus unknownNCT05850845
- A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients with Primary Membranous Nephropathy (ZL-1103-014)TerminatedNCT05810961Phase 2
- Evaluate The Efficacy, Safety, Pharmacokinetics And Pharmacodynamics Of EVER001CompletedNCT05800873Phase 1
- Application of Hyperspectral Imaging in the Diagnosis of Glomerular DiseasesStatus unknownNCT05797051
- Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TACStatus unknownNCT05797038
- Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous NephropathyStatus unknownNCT05782933Not applicable
- An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular DiseasesActive, not recruitingNCT05732402Phase 1/2
- A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous NephropathyActive, not recruitingNCT05707377Phase 2/3
- COVID-19 Infection and Idiopathic Membranous NephropathyStatus unknownNCT05691179
- Prognostic Model of Rituximab in the Treatment of MNStatus unknownNCT05667909
- Prognostic Model of GC/TAC in the Treatment of MNStatus unknownNCT05667896
- Prognostic Model of GC/CTX in the Treatment of MNStatus unknownNCT05667883
- The Influencing Factors and Mechanism of High Incidence of Thrombotic Events in Patients With MN and DKDActive, not recruitingNCT05656963
- In Vitro Immunomodulation in Membranous Nephropathy RelapsesCompletedNCT05428605Not applicable
- A Phase Ib/ Ⅱ Clinical Study of MIL62 in Primary Membranous NephropathyCompletedNCT05398653Phase 1/2
- Evaluate the Efficacy and Safety of SHR1459 Tablets in Patients With Primary Membranous NephropathyActive, not recruitingNCT05136456Phase 2